- $834.06m
- $2.05bn
- $235.82m
Brief: Kayne Anderson Bdc Announces March 31, 2026 Financial Results
U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Ford, GM
Brief: Kayne Anderson BDC Agrees To $200 Million Private Placement
Brief: Kayne Anderson BDC Announces March 31, 2025 Financial Results And Declares Second Quarter 2025 Dividend Of $0.40 Per Share
Brief: Kayne Anderson BDC Inc QTRLY Net Asset Value Of $16.70 Per Share
Brief: Kayne Anderson Bdc Amends Senior Secured Revolving Credit Facility
Brief: Kayne Anderson Bdc Inc Amends Senior Secured Revolving Credit Facility
Brief: Kayne Anderson BDC Says Maturity Date On $400 Mln Commitments Extended To November 22, 2029